Teva
Mega deal: Teva acquires Emalex for approximately $900 million
The Israeli pharmaceutical giant is accelerating its growth strategy and adding to its portfolio a groundbreaking treatment for Tourette syndrome in children.
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
Teva honored for gender equality as women reach 43% of senior management in Israel
Teva collaborates on skin disease treatment, releases targets
Media Comment: Media-assisted legal irresponsibility
We need remind ourselves that all instruments of power, governmental and non-governmental, are never totally free of weaknesses.
Warren Buffett wagers big on Teva, and on Israel
The purchase initially sent share prices soaring by 12 percent.
Beit Berl College to re-train former Teva workers as chemistry teachers
The Education Ministry will cover the cost of tuition loans that will convert into grants after two years of teaching in the field.
Outrage as Teva charges $18,275 for generic drug in US
B "Teva Pharmaceutical's new generic version of the drug Syprine… will cost 28 times what Syprine cost in 2010. We have a crisis in drug prices in this country," Senator Bernie Sanders said.
Embattled Teva fined NIS 75m. for bribing foreign officials
This comes as the company is laying off thousands of workers in an effort to balance its books
Teva delays 33% of Jerusalem layoffs until 2019
The company making its first gesture, albeit a small one, to the workers and the Histadrut.
This week in Jerusalem: Life after Teva
A proposal was made that there should be an incentive to other firms in Jerusalem to absorb as many dismissed Teva employees as possible.
Teva’s collapse – Israel’s biotech recovery
Over the past two years, Teva lost $57b. of value, leaving it with a remaining market value of $19b. It owes about $35b.
Value of Israeli mergers and acquisitions deals drops in 2017
The average price of each transaction fell by about 38%, but there was a slight 9% in the number of transactions this year, up to 131 M&A deals.
Rivlin: Major local companies should stay in Israel
"Israel is poor in natural resources, but rich in human resources."